Amniotic fluid lactate (AFL): a new predictor of labor outcome in dystocic deliveries

Abstract

Purpose of this Review: Even today, hundreds of thousands of women die or suffer high levels of morbidity associated with childbirth. One of the most common causes is halted labor progress, or labor dystocia. There have been no developments in the diagnosis or treatment of dystocic deliveries since Friedman designed the Partogram in the 1950s. Oxytocin is the only treatment for dystocic labor. Sometimes, oxytocin is a lifesaver for the woman, especially in severe postpartum hemorrhages. At the same time, it is also one of the most overused drugs in obstetric care. This review article is meant to provide a short overview of the current knowledge of uterine metabolism during labor, uterine lactate production, and its association with labor dystocia. The article also intends to reflect new ways of thinking regarding practical recommendations for treating labor dystocia and offer a look at the future of dystocic labor management.

Keywords:

• Labor dystocia
• metabolic status
• lactate
• cesarean section
• oxytocin

Disclosure statement

The author of the article reports no conflict of interest.

Additional information

Funding

No specific funding was obtained.